focus -WSS

focus

author：leisure time 2025-10-02 22:40:22 - browse：447

Light hits on the portrait of George Washington on a one dollar bill. The portrait is surrounded by white and red tablets coming out of a pill bottle, as well as some coins — coverage from STAT — Adobe

WASHINGTON — Pharmaceutical companies are doing anything they can to stop President Biden’s Medicare program from being able to negotiate prices for their products, including suing the government. Experts say their efforts might actually benefit Biden by reminding voters that he’s taking on big drug companies.

When Democrats passed a law directing Medicare to negotiate drug prices, it was considered a major achievement. The new law, two decades in the making, gives Biden an accomplishment to both tout for himself and criticize Republicans for opposing — no Republicans voted to let Medicare negotiate drug prices.

Medicare price negotiation is popular with voters, as are the law’s price-inflation limits, and it includes additional, direct benefits for older adults that are easy to understand. It caps annual out-of-pocket retail-drug spending for seniors and people with disabilities, and it caps their monthly spending on insulin at $35.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： At least 13 dead in Texas as scorching temps continue
Next article： For BCIs, commercial hurdles may be bigger than scientific ones

WSS

Who is Magistrate Judge Moxila Upadhyaya in Trump's Jan. 6 case?

For BCIs, commercial hurdles may be bigger than scientific ones

People can get long Covid without testing positive for virus: Study

A cyberattack has disrupted hospitals and health care in several states

What Henrietta Lacks settlement says about racism in medicine

What the cancer research community can learn from the Covid response

hotspot

focus

Wikipedia

Continuity nursing helped my family in our darkest PICU moments

California store owner shot dead in dispute over displaying Pride flag: Police

Guidelines to prevent youth baseball injuries need more muscle

Hospital at home shows how to bring innovation to health care

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Former Pear Therapeutics executives start new VC firm

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

How the first Native Hawaiian psychiatrist helped diversify medicine

Virginia high school admissions case could be legal follow

What Henrietta Lacks settlement says about racism in medicine

focus

Treeline, Josh Bilenker's next biotech, is cloaked in mystery

ProMED, early warning system on disease outbreaks, in peril

Health officials lay out plans to cope with respiratory virus season

Trans patients at the end of life deserve respect and dignity

Stem cell clinics for heart failure: buyer be wary

Vivek Ramaswamy made waves in the debate, much as in biotech

leisure time

leisure time

explore

knowledge